Abstract

Research Article

Diagnostic accuracy of apparent diffusion coefficient (ADC) in differentiating low- and high-grade gliomas, taking histopathology as the gold standard

Raheel Khan, Atiq-ur-Rehman Selehria, Hafsa Aquil, Atif Sheraz, Sara Khan, Najwa Zahoor and Anashia Kayani*

Published: 10 April, 2023 | Volume 7 - Issue 1 | Pages: 013-019

Gliomas are known to be one of the most grievous malignant central nervous system (CNS) tumors and have a high mortality rate with a low survival rate severe disability and increase risk of recurrence. Aim of his study is to determine the diagnostic accuracy of apparent diffusion coefficient (ADC) in differentiating low-grade and high-grade gliomas, taking histopathology as the gold standard. It is a Cross-sectional validation study conducted at the Armed Forces Institute of Radiology and Imaging, (AFIRI) Rawalpindi, Pakistan from 28th February 2022 to 27th August 2022.
Materials and methods: A total of 215 patients with focal brain lesions of age 25-65 years of either gender were included. Patients with a cardiac pacemaker, breastfeeding females, de-myelinating lesions and malignant infiltrates, and renal failure were excluded. Then diffusion-weighted magnetic resonance imaging was performed on each patient by using a 1.5 Tesla MR system. The area of greatest diffusion restriction (lowest ADC) within the solid tumor component was identified while avoiding areas of peritumoral edema. Results of ADC were interpreted by a consultant radiologist (at least 5 years of post-fellowship experience) for high or low-grade glioma. After this, each patient has undergone a biopsy in the concerned ward, and histopathology results were compared with ADC findings. 
Results: Overall sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of apparent diffusion coefficient (ADC) in differentiating low- and high-grade gliomas, taking histopathology as the gold standard was 93.65%, 87.64%, 91.47%, 90.70% and 91.16% respectively. 
Conclusion: This study concluded that apparent diffusion coefficient (ADC) is the non-invasive modality of choice with high diagnostic accuracy in differentiating low- and high-grade gliomas.

Read Full Article HTML DOI: 10.29328/journal.jro.1001047 Cite this Article Read Full Article PDF

References

  1. Al-Agha M, Abushab K, Quffa K, Al-Agha S, Alajerami Y, Tabash M. Efficiency of High and Standard bValue Diffusion-Weighted Magnetic Resonance Imaging in Grading of Gliomas. J Oncol. 2020 Sep 14;2020:6942406. doi: 10.1155/2020/6942406. PMID: 33005190; PMCID: PMC7509551.
  2. Wesseling P, Capper D. WHO 2016 Classification of gliomas. Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-150. doi: 10.1111/nan.12432. PMID: 28815663.
  3. Fawzy FM, Almassry HN, Ismail YM. Preoperative glioma grading by MR diffusion and MR spectroscopic imaging. Egyptian Journal of Radiology and Nuclear Medicine (Online). 2016; 47(4): 1539-1548.
  4. Zhang L, Min Z, Tang M, Chen S, Lei X, Zhang X. The utility of diffusion MRI with quantitative ADC measurements for differentiating high-grade from low-grade cerebral gliomas: Evidence from a meta-analysis. J Neurol Sci. 2017 Feb 15;373:9-15. doi: 10.1016/j.jns.2016.12.008. Epub 2016 Dec 9. Erratum in: J Neurol Sci. 2017 Apr 15;375:103-106. PMID: 28131237.
  5. Darbar A, Waqas M, Enam SF, Mahmood SD. Use of Preoperative Apparent Diffusion Coefficients to Predict Brain Tumor Grade. Cureus. 2018 Mar 7;10(3):e2284. doi: 10.7759/cureus.2284. PMID: 29740523; PMCID: PMC5938001.
  6. Qin JB, Zhang H, Wang XC, Tan Y, Wu XF. Combination value of diffusion-weighted imaging and dynamic susceptibility contrast-enhanced MRI in astrocytoma grading and correlation with GFAP, Topoisomerase IIα and MGMT. Oncol Lett. 2019 Sep;18(3):2763-2770. doi: 10.3892/ol.2019.10656. Epub 2019 Jul 24. PMID: 31452754; PMCID: PMC6704283.
  7. Zhang L, Min Z, Tang M, Chen S, Lei X, Zhang X. The utility of diffusion MRI with quantitative ADC measurements for differentiating high-grade from low-grade cerebral gliomas: Evidence from a meta-analysis. J Neurol Sci. 2017 Feb 15;373:9-15. doi: 10.1016/j.jns.2016.12.008. Epub 2016 Dec 9. Erratum in: J Neurol Sci. 2017 Apr 15;375:103-106. PMID: 28131237.
  8. Al-Sharydah AM, Al-Arfaj HK, Saleh Al-Muhaish H, Al-Suhaibani SS, Al-Aftan MS, Almedallah DK, Al-Abdulwahhab AH, Al-Hedaithy AA, Al-Jubran SA. Can apparent diffusion coefficient values help distinguish between different types of pediatric brain tumors? Eur J Radiol Open. 2019 Jan 4;6:49-55. doi: 10.1016/j.ejro.2018.12.004. PMID: 30627595; PMCID: PMC6321863.
  9. Yao R, Cheng A, Liu M, Zhang Z, Jin B, Yu H. The Diagnostic Value of Apparent Diffusion Coefficient and Proton Magnetic Resonance Spectroscopy in the Grading of Pediatric Gliomas. J Comput Assist Tomogr. 2021 Mar-Apr 01;45(2):269-276. doi: 10.1097/RCT.0000000000001130. PMID: 33346568; PMCID: PMC7972297.
  10. Abd El-Salam SM, Mokhtar O. Diagnostic accuracy of diffusion-weighted imaging in evaluation of high and low-grade pediatric brain tumors. Medical Journal of Cairo University. 2019; 87(3):1877-83. DOI:21608/mjcu.2019.54033
  11. Ryu YJ, Choi SH, Park SJ, Yun TJ, Kim JH, Sohn CH. Glioma: application of whole-tumor texture analysis of diffusion-weighted imaging for the evaluation of tumor heterogeneity. PLoS One. 2014 Sep 30;9(9):e108335. doi: 10.1371/journal.pone.0108335. PMID: 25268588; PMCID: PMC4182447.
  12. Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology. 2002 Jul;224(1):177-83. doi: 10.1148/radiol.2241010637. PMID: 12091680.
  13. Higano S, Yun X, Kumabe T, Watanabe M, Mugikura S, Umetsu A, Sato A, Yamada T, Takahashi S. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology. 2006 Dec;241(3):839-46. doi: 10.1148/radiol.2413051276. Epub 2006 Oct 10. PMID: 17032910.
  14. Chen Z, Ma L, Lou X, Zhou Z. Diagnostic value of minimum apparent diffusion coefficient values in prediction of neuroepithelial tumor grading. J Magn Reson Imaging. 2010 Jun;31(6):1331-8. doi: 10.1002/jmri.22175. PMID: 20512884.
  15. Wu CC, Guo WY, Chen MH, Ho DM, Hung AS, Chung HW. Direct measurement of the signal intensity of diffusion-weighted magnetic resonance imaging for preoperative grading and treatment guidance for brain gliomas. J Chin Med Assoc. 2012 Nov;75(11):581-8. doi: 10.1016/j.jcma.2012.08.019. Epub 2012 Nov 2. PMID: 23158036.
  16. Zhang L, Min Z, Tang M, Chen S, Lei X, Zhang X. The utility of diffusion MRI with quantitative ADC measurements for differentiating high-grade from low-grade cerebral gliomas: Evidence from a meta-analysis. J Neurol Sci. 2017 Feb 15;373:9-15. doi: 10.1016/j.jns.2016.12.008. Epub 2016 Dec 9. Erratum in: J Neurol Sci. 2017 Apr 15;375:103-106. PMID: 28131237.
  17. Min ZG, Liu HJ, Li M, Liu LH, Jin CW, Zhang M. [Accuracy of MR perfusion weighted imaging for cerebral glioma grading: a meta-analysis]. Zhonghua Yi Xue Za Zhi. 2010 Nov 9;90(41):2927-31. Chinese. PMID: 21211399.
  18. van Dijken BRJ, van Laar PJ, Holtman GA, van der Hoorn A. Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis. Eur Radiol. 2017 Oct;27(10):4129-4144. doi: 10.1007/s00330-017-4789-9. Epub 2017 Mar 22. PMID: 28332014; PMCID: PMC5579204.
  19. Wang QP, Lei DQ, Yuan Y, Xiong NX. Accuracy of ADC derived from DWI for differentiating high-grade from low-grade gliomas: Systematic review and meta-analysis. Medicine (Baltimore). 2020 Feb;99(8):e19254. doi: 10.1097/MD.0000000000019254. PMID: 32080132; PMCID: PMC7034741.
  20. Arvinda HR, Kesavadas C, Sarma PS, Thomas B, Radhakrishnan VV, Gupta AK, Kapilamoorthy TR, Nair S. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol. 2009 Aug;94(1):87-96. doi: 10.1007/s11060-009-9807-6. Epub 2009 Feb 20. Retraction in: J Neurooncol. 2013 Sep;114(2):255. PMID: 19229590.
  21. Kang Y, Choi SH, Kim YJ, Kim KG, Sohn CH, Kim JH, Yun TJ, Chang KH. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade. Radiology. 2011 Dec;261(3):882-90. doi: 10.1148/radiol.11110686. Epub 2011 Oct 3. PMID: 21969667.
  22. Lam WW, Poon WS, Metreweli C. Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol. 2002 Mar;57(3):219-25. doi: 10.1053/crad.2001.0741. PMID: 11952318.
  23. Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology. 2006 Jun;239(3):632-49. doi: 10.1148/radiol.2393042031. PMID: 16714455.
  24. Koral K, Alford R, Choudhury N, Mossa-Basha M, Gargan L, Gimi B, Gao A, Zhang S, Bowers DC, Koral KM, Izbudak I. Applicability of apparent diffusion coefficient ratios in preoperative diagnosis of common pediatric cerebellar tumors across two institutions. Neuroradiology. 2014 Sep;56(9):781-8. doi: 10.1007/s00234-014-1398-z. Epub 2014 Jun 29. PMID: 24974083.
  25. Zitouni S, Koc G, Doganay S, Saracoglu S, Gumus KZ, Ciraci S, Coskun A, Unal E, Per H, Kurtsoy A, Kontas O. Apparent diffusion coefficient in differentiation of pediatric posterior fossa tumors. Jpn J Radiol. 2017 Aug;35(8):448-453. doi: 10.1007/s11604-017-0652-9. Epub 2017 May 26. PMID: 28550357.
  26. Gimi B, Cederberg K, Derinkuyu B, Gargan L, Koral KM, Bowers DC, Koral K. Utility of apparent diffusion coefficient ratios in distinguishing common pediatric cerebellar tumors. Acad Radiol. 2012 Jul;19(7):794-800. doi: 10.1016/j.acra.2012.03.004. Epub 2012 Apr 17. PMID: 22513110.
  27. Fan GG, Deng QL, Wu ZH, Guo QY. Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? Br J Radiol. 2006 Aug;79(944):652-8. doi: 10.1259/bjr/25349497. Epub 2006 Apr 26. PMID: 16641420.
  28. Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology. 2006 Mar;48(3):150-9. doi: 10.1007/s00234-005-0030-7. Epub 2006 Feb 10. PMID: 16470375.
  29. Lam WW, Poon WS, Metreweli C. Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol. 2002 Mar;57(3):219-25. doi: 10.1053/crad.2001.0741. PMID: 11952318.
  30. Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, Baba Y, Oya N, Kuratsu J, Yamashita Y. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology. 2007 May;243(2):493-9. doi: 10.1148/radiol.2432060450. Epub 2007 Mar 13. PMID: 17356177.
  31. Oh J, Henry RG, Pirzkall A, Lu Y, Li X, Catalaa I, Chang S, Dillon WP, Nelson SJ. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging. 2004 May;19(5):546-54. doi: 10.1002/jmri.20039. PMID: 15112303.
  32. Barker FG 2nd, Chang SM, Huhn SL, Davis RL, Gutin PH, McDermott MW, Wilson CB, Prados MD. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer. 1997 Sep 1;80(5):936-41. PMID: 9307194.
  33. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology. 2002 Sep 24;59(6):947-9. doi: 10.1212/wnl.59.6.947. PMID: 12297589.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?